G. Getz

Immunology · 2011–2018

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom G. Getz trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lloyd J. Old (in Immunology)

Who trusts G. Getz

  1. Nicholas McGranahan (in Oncology)
  2. Charles Swanton (in Oncology)

Papers from G. Getz's perspective

Ordered by how strongly the researchers G. Getz trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  2. An immune-active tumor microenvironment favors clinical response to ipilimumab (Cancer Immunology and Immunotherapy)
  3. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps (Nature Reviews. Cancer)
  4. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  5. An immunogenic personal neoantigen vaccine for patients with melanoma (Nature)
  6. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (Cancer Cell)
  7. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. (Journal of Clinical Oncology)
  8. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (Science)
  9. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (Nature)
  10. Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1 (Immunity)

Their papers